Future care for long-term cancer survivors: towards a new model

dc.contributor
Universitat Ramon Llull. Esade
dc.contributor.author
provencio, mariano
dc.contributor.author
Romero Villela, Pamela Nicole
dc.contributor.author
Tabernero, Josep
dc.contributor.author
Vera, Ruth
dc.contributor.author
Vicente Baz, David
dc.contributor.author
Arraiza Armendáriz, Antonio
dc.contributor.author
Camps, Carlos
dc.contributor.author
FELIP, ENRIQUETA
dc.contributor.author
Garrido López, Pilar
dc.contributor.author
Gaspar, Bernard
dc.contributor.author
Llombart Cussac, Antonio
dc.contributor.author
López González, A.
dc.contributor.author
Magallón Pedrera, Isabel
dc.contributor.author
IBANEZ DE CACERES, INMACULADA
dc.contributor.author
Martínez-Olmos, Francisco José
dc.contributor.author
Mur, Carlos
dc.contributor.author
Navarro Ruiz, Andrés
dc.contributor.author
Pastor del Campo, Aida
dc.contributor.author
Peiró, Manel
dc.contributor.author
Polo, J.
dc.contributor.author
Rodríguez-Lescure, Á.
dc.date.accessioned
2026-02-19T14:12:07Z
dc.date.available
2026-02-19T14:12:07Z
dc.date.issued
2022
dc.identifier.issn
1699-048X
dc.identifier.uri
https://hdl.handle.net/20.500.14342/5012
dc.description.abstract
Purpose: The increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to increase the cost of LCS care. The aim of this study was to obtain information that would allow to optimise the current model of health management in Spain to adapt it to one of efficient LCS patient care. Methods: This qualitative study was carried out using Delphi methodology. An advisory committee defined the criteria for participation, select the panel of experts, prepare the questionnaire, interpret the results and draft the final report. Results: 232 people took part in the study (48 oncologists). Absolute consensus was reached in three of the proposed sections: oncological epidemiology, training of health professionals and ICT functions. Conclusion: The role of primary care in the clinical management of LCS patients needs to be upgraded, coordination with the oncologist and hospital care is essential. The funding model needs to be adapted to determine the funding conditions for new drugs and technologies.
dc.format.extent
13 p.
dc.language.iso
eng
dc.publisher
Springer-Verlag Italia s.r.l.
dc.relation.ispartof
Clinical and Translational Oncology
dc.rights
© L'autor/a
dc.rights
Attribution 4.0 International
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Long cancer survivor
dc.title
Future care for long-term cancer survivors: towards a new model
dc.type
info:eu-repo/semantics/article
dc.description.version
info:eu-repo/semantics/publishedVersion
dc.embargo.terms
cap
dc.identifier.doi
http://doi.org/10.1007/s12094-021-02696-5
dc.rights.accessLevel
info:eu-repo/semantics/openAccess


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Esade [293]